Welcome to this month’s RxStrategies Clinical Insights, a concise communication to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approvals Keytruda® (pembrolizumab) – New Orphan Drug Approval September 4, 2014 – The U.S. Food and Drug Administration approvedKeytruda® (pembrolizumab) for treatment of patients with advanced or unresectable…

 Download print version. Welcome to this month’s RxStrategies Clinical Insights, a concise communication to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approvals Cerdelga™ (eliglustat) – New Orphan Drug Approval August 19, 2014 – The U.S. Food and Drug Administration approved Cerdelga™ (eliglustat) for the long-term treatment of…

We would like to introduce the RxStrategies Clinical Insights a new concise communication to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place with such topics as new drug product approval information, generic launches, drug product recalls and safety alerts. This will be a frequent communication along with a…